| Date | Event |
| 5-Nov-09 | NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report |
| 4-Nov-09 | Nektar Therapeutics Financial Results Call scheduled for 5:00 pm ET today |
| 4-Nov-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 4-Nov-09 | Earnings announcement |
| 13-Oct-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure |
| 2-Oct-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob |
| 22-Sep-09 | Nektar Therapeutics upgraded by BMO Capital Markets |
| 22-Sep-09 | Price hit new 52-week high ($10.64) |
| 21-Sep-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure |
| 21-Sep-09 | Price hit new 52-week high ($9.91) |
| 11-Sep-09 | Price hit new 52-week high ($8.61) |
| 5-Aug-09 | NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report |
| 4-Aug-09 | Nektar Therapeutics Earnings Call scheduled for 5:00 pm ET today |
| 4-Aug-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition |
| 8-May-09 | NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report |
| 6-May-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition |
| 6-Mar-09 | NEKTAR THERAPEUTICS Files SEC form 10-K, Annual Report |
| 4-Mar-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Financial Statements and Exhibits |
| 2-Mar-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 25-Feb-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure |
| 29-Jan-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits |
| 2-Jan-09 | NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disp |
| 21-Nov-08 | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits |
| 6-Nov-08 | NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |